infoOh, no. Your browser is out of date or incompatible with our site.

Continue to expand your knowledge and complement your daily medical practice.

Upgrade your browser to a newer version or try using the following options to navigate efficiently and safely.

  • {{notification.subject}}
    {{notification.timestamp | calculateTimeInWeeks('week','weeks', 'This')}}
app install close

Add a shortcut to Diálogo Roche

app install close

Add a shortcut to Diálogo Roche: press and then add it to your home screen.


Novel Treatment for Hemophilia A - Emicizumab


Dr. Miguel Escobar

Hematologist. Professor at McGovern Medical School at The University of Texas. WFH Medical Board Member.

Did you miss the event or want to see it again?
You can enter the following link and access the recording and the materials presented at the event.

How to access the content in Diálogo Roche?
To view the materials you must be registered in Diálogo Roche.
If you are not registered yet, you can do so here.

If you have questions with the registration, you can consult the step-by-step registration guide.

The registration is for a single time and will allow you to enter all the events and educational content of the portal.

This material may contain information on investigational medicinal products or on indications not yet approved for the sole purpose of reactive use in response to inquiries received by healthcare professionals in order to provide medical and/or scientific information.

Roche does not recommend the use of any product in any indication, dosage or route of administration that is not clearly mentioned in the product's prescribing information approved by the local regulatory authority.

The views and opinions expressed in this material are solely the responsibility of the authors and do not necessarily represent the views of Roche.